Results 111 to 120 of about 1,315,413 (357)
Conjugacy classes of maximal cyclic subgroups and nilpotence class of $p$-groups [PDF]
, 2022 M. Bianchi, R. D. Camina, Mark L. Lewis
openalex +1 more source
Spherical affine cones for maximal reductive subgroups in exceptional cases [PDF]
, 2013 Given a complex simply connected simple algebraic group G of exceptional type and a maximal parabolic subgroup P of G, we classify all triples (G,P,H) such that H is a maximal reductive subgroup of G acting spherically on G/P .
Niemann, Bruno
core
Quantitative Assessment of Upper Limb Ataxia Using a Virtual Reality‐Based Evaluation System
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Cerebellar ataxia impairs coordination and balance, reducing quality of life. Conventional clinical scales, including the Scale for the Assessment and Rating of Ataxia (SARA) and the International Cooperative Ataxia Rating Scale (ICARS), are widely used to assess ataxia but are limited by subjectivity and inter‐rater variability ...
Masayuki Sato +5 more
wiley +1 more source
Some designs and codes from L_2(q) [PDF]
Transactions on Combinatorics, 2014 For $q \in \{7,8,9,11,13,16\}$, we consider the primitive actions of $L_2(q)$ and use Key-Moori Method 1 as described in [Codes, designs and graphs from the Janko groups {$J_1$} and {$J_2$}, {\em J. Combin. Math. Combin.
Jamshid Moori +1 more
doaj
On maximal subgroups of infinite index in branch and weakly branch groups [PDF]
Journal of Algebra, 2020 Dominik Francoeur
semanticscholar +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan +22 more
wiley +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Independence and maximal subgroups
Illinois Journal of Mathematics, 1996 \(G\) denotes a finite group and \(M(G)\) the set of all maximal subgroups of \(G\). A simplicial complex \((M,{\mathcal T})\) is a finite set \(M\) and a set \(\mathcal T\) of subsets of \(M\) such that: (1) If \(m\in M\), then \(\{m\}\in{\mathcal T}\). (2) If \(A\in{\mathcal T}\) and \(B\subset A\), then \(B\in{\mathcal T}\).
openaire +3 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source